[Translation] A randomized, double-blind, placebo-controlled multicenter clinical trial evaluating DH001 tablets for the prevention of cardiotoxicity in cancer patients treated with doxorubicin
1. 初步评估DH001对于肿瘤患者使用阿霉素后发生心脏毒性的预防效果;
2. 探索合适的用药剂量,为后续确证性研究的用药剂量提供依据;
3. 评估DH001对于阿霉素治疗肿瘤患者的疗效影响;
4. 评估DH001在经阿霉素治疗的肿瘤患者中的安全性。
[Translation] 1. Preliminary evaluation of the preventive effect of DH001 on cardiotoxicity in tumor patients treated with doxorubicin;
2. Explore the appropriate dosage and provide a basis for the dosage of follow-up confirmatory research;
3. Evaluate the effect of DH001 on the efficacy of doxorubicin in treating tumor patients;
4. Evaluate the safety of DH001 in tumor patients treated with doxorubicin.